Orser Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Orser Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-4,030	Closed	-$234K	–	45
2023 Q3	$234K	Hold	4,030	–	–	0.23%	50
2023 Q2	$258K	Hold	4,030	–	–	0.26%	50
2023 Q1	$279K	Hold	4,030	–	–	0.31%	47
2022 Q4	$290K	Hold	4,030	–	–	0.42%	40
2022 Q3	$286K	Hold	4,030	–	–	0.51%	33
2022 Q2	$310K	Hold	4,030	–	–	0.4%	42
2022 Q1	$294K	Hold	4,030	–	–	0.18%	72
2021 Q4	$251K	Sell	4,030 -1,000	-20%	-$58.7K	0.13%	86
2021 Q3	$298K	Hold	5,030	–	–	0.16%	76
2021 Q2	$336K	Buy	5,030 +200	+4%	+$13K	0.17%	77
2021 Q1	$305K	Hold	4,830	–	–	0.2%	75
2020 Q4	$300K	Hold	4,830	–	–	0.19%	76
2020 Q3	$291K	Hold	4,830	–	–	0.23%	64
2020 Q2	$284K	Sell	4,830 -180	-4%	-$10.8K	0.26%	53
2020 Q1	$279K	Hold	5,010	–	–	0.39%	46
2019 Q4	$319K	Buy	+5,010	New	+$287K	0.31%	63
2019 Q3	–	Sell	-2,800	Closed	-$227K	–	70
2019 Q2	$227K	Sell	2,800 -2,210	-44%	-$103K	0.23%	64
2019 Q1	$239K	Sell	5,010 -32,720	-87%	-$1.63M	0.26%	63
2018 Q4	$2.11M	Hold	37,730	–	–	2.43%	11
2018 Q3	$2.11M	Sell	37,730 -1,070	-3%	-$63.5K	2.02%	13
2018 Q2	$2.2M	Sell	38,800 -2,210	-5%	-$119K	1.91%	11
2018 Q1	$2.1M	Buy	+41,010	New	+$2.64M	1.95%	11

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Orser Capital Management's BMY Position: Q4 2023 in Review

Orser Capital Management sold out of Bristol-Myers Squibb (BMY) in Q4 2023, closing a stake of 4,030 shares — an estimated $234K sold.

Orser Capital Management first reported a position in BMY in Q1 2018 and held it in 22 quarters. The position peaked at $2.2M in Q2 2018. 2,363 funds tracked by Wall St. Rank hold BMY as of Q4 2023.

Orser Capital Management reported no remaining Bristol-Myers Squibb position as of Q4 2023 after selling out during the quarter.
Orser Capital Management sold 4,030 Bristol-Myers Squibb shares in Q4 2023, an estimated $234K.
Orser Capital Management first reported a position in Bristol-Myers Squibb in Q1 2018 and held it in 22 quarters.
Orser Capital Management's Bristol-Myers Squibb position peaked at $2.2M in Q2 2018.
2,363 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2023.

Based on Orser Capital Management's 13F filing for Q4 2023, filed 9 Jan 2024.